Bronchoscopic Lung Volume Reduction – Inclusion / Exclusion Criteria

These are only general guidelines and every patient will be evaluated on an individual basis.

Inclusion:

  • Ex-smokers (≥4 months)
  • PFT:
    • Post BD FEV1 15 – 45%
    • TLC ≥100%
    • RV ≥150%
  • 6MWD
    • ≥ 100 – <500 meters after pulmonary rehabilitation program
  • BMI <35 Kg/m2
  • Completed pulmonary rehabilitation program (or is enrolled and completed 6-8 sessions)
  • ABG: PaCO2 <60 on room air, PaO2 >45 on room air
  • Stable on prednisone <20mg/day

Exclusion:

  • Any contraindication to bronchoscopy and/or general anesthesia
  • Lung findings:
    • Pulmonary nodule requiring work up
    • Giant bullae (>1/3 hemithorax). May be referred for bullectomy
  • Comorbidities:
    • Recent CV event (6 months)
    • Recent CVA (3 months)
    • Known uncontrolled PAH sPAP >60
  • Prior lobectomy, LVRS, lung transplant, median sternotomy
  • Careful consideration in:
    • CHF w/EF <45%
    • FEV 1 < 15%
    • DLCO <20%
    • Baseline 6MWD <100m
    • Lack of access to medical care

Tests required within 1 year:

  • Chest CT:
    • Chest CT with SD (super dimension protocol done at HFHS)
    • We can rule in with outside CT (minimum requirement HRCT inspiration only <1.5mm cuts, contrasted images are not analyzable) if done within 1 year. However, we do not rule out based upon outside images
  • Complete PFT
  • ABG
  • 6MWT
  • TTE
  • Perfusion scan ordered on an individual basis. To be determined after IP clinic visit and complete evaluation

Lobe selection process

  1. Little to No Collateral Ventilation
    • Fissure completeness ≥80% preoperatively (StratX). Fissure <80% rules out
    • Intraoperative confirmation with balloon (Chartis) that lobe is CV-
  2. Higher Destruction
    • Emphysema score ≥45% on QCT (Stratx)
    • Prefer lobe with greatest destruction
  3. Larger Lobe Volume
  4. Less Perfusion
    • Perfusion scan may be used when multiple valid target lobes are available
    • Consider if ipsilateral heterogeneity score is low
  5. Greater Heterogeneity
    • Heterogeneity score ≥10% (difference in emphysema score between the target and ipsilateral lobe)